NCT07152834 - Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction | Biotech Hunter

Enrollment

734

Participants

Timeline

Start Date

August 6, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

January 5, 2026

Conditions

Alpha 1-antitrypsin Deficiency (AATD)

Interventions

DIAGNOSTIC_TEST

Blood Sampling

"For AAT Level: Residual serum from routine blood samples drawn for standard clinical care will be aliquoted into polypropylene cryotubes.~For Genetic Testing: A separate capillary blood sample will be obtained via finger prick using a sterile lancet and collected on a designated filter paper."

Trial Locations (1)

48000

RECRUITING

Muğla Training and Research Hospital, Muğla

All Listed Sponsors

collaborator

PROGENIKA BIOPHARMA, A GRIFOLS Company

UNKNOWN

lead

Muğla Sıtkı Koçman University

OTHER